05/14/2026
A Revolutionary Discovery in Cancer Treatment Independent of Organ Origin -Davis Joseph’s third major discovery in 18 months: this time in Cancer
- Published in Nature Portfolio Scientific journal: the most prestigious scientific publisher in the world (https://www.nature.com/articles/s41420-026-03066-2)
Davis Joseph’s work has, for the first time, overturned two-century-old paradigms:
1. The Organ-Specific Paradigm: Traditionally, cancers have been treated based on the organs where they originate. Since cancer was first identified in the human body, a universal “pan-organ” denominator had never been proposed.
2. The Isolationist Paradigm: Cancer biochemistry has historically been studied in isolation—one pathway at a time—without accounting for the complex interactions between proteins and regulatory RNAs that characterize a living organism.
In this breakthrough work, Davis Joseph identified three universal cancer types based on the malfunction of specific proteins and regulatory RNAs:
• Type 1: Cells lacking a functional p14ARF or p53 gene.
• Type 2: Cells lacking a functional DINO lncRNA.
• Type 3: Cells exhibiting abnormally high MDM2 protein activity.
By developing a unified therapeutic theory, Joseph has identified novel targets for treating cancer regardless of the primary organ. This paves the way for a revolutionary, organ-agnostic approach to oncology.
He presented his work for the first time in SIPS 2025 in a plenary paper. As always SIPS is the fountain of new discoveries
SIPS 2026 will have Davis presenting another new groundbreaking discovery:: https://www.flogen.org/sips2026/ . Come and be part of the history.
SIPS2025 sips2026 SIPS
